審議結果報告書 - pmda.go.jp
29 10 . . 25 mg 125 mg . . 28 10 31 . . 29 27 . . . . . . . . 29 7 14 . . . . . 25 mg 125 mg . . 28 10 31 . 1 25 mg 125 mg . 1 . . C24H29N7O2. . 6- -8- -5- -2-{[5-( -1- ) -2- ] . } [2,3-d] -7(8H)- . 6-Acetyl-8-cyclopentyl-5-methyl-2-{ [5-(piperazin-1-yl)pyridin-2-yl] amino} pyrido [2,3-d]. pyrimidin-7(8H)-one . . _ _ . . . . . . . . . . 1 1 125 mg 3 . 1 1 . . . . 2. _ _ . . 1 . 29 6 16 . . . . 25 mg 125 mg . . 28 10 31 . 1 25 mg 125 mg . . 1 . 1 125 mg 3 1 . 1 . . . 1. ........................................ .................... 6. 2. ........................................ ........................................ ........ 7. 3.
イブランスカプセル_ファイザー株式会社_審査報告書 2 BSA bovine serum albumin ウシ血清アルブミン BSEP bile salt export pump 胆汁酸排泄ポンプ
Download 審議結果報告書 - pmda.go.jp
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: